编辑信息 |
Editor Ted Gansler, MD, MBA, MPH American Cancer Society Associate Editors Durado Brooks, MD, MPH American Cancer Society Keith A. Delman, MD, FACS Winship Cancer Institute of Emory University | Senior Director, Journals and Books Publishing Esmeralda Galán Buchanan American Cancer Society Managing Editor Jin Hee Kim American Cancer Society
| Publisher Shawn Morton Wiley Senior Production Editor Rich Nagurka Wiley |
EDITORIAL ADVISORY BOARD Walter J. Curran, Jr., MD Winship Cancer Institute of Emory University Gini Fleming, MD University of Chicago Medicine Susan Gapstur, PhD, MPH American Cancer Society Frederick L. Greene, MD Levine Cancer Institute Ahmedin Jemal, DVM, PhD American Cancer Society | Cathy Meade, PhD, RN, FAAN Moffitt Cancer Center Kevin Oeffinger, MD Duke University School of Medicine William K. Oh, MD Mount Sinai School of Medicine Nancy D. Perrier, MD, FACS UT MD Anderson Cancer Center | William Phelps, PhD American Cancer Society Charles R. Thomas, Jr., MD Oregon Health and Science University Andrew J. Vickers, PhD Memorial Sloan-Kettering Cancer Center |
EDITORIAL ADVISOR CHINESE EDITION Zhiyuan Zheng, PhD American Cancer Society |
|
Conflicts of Interest Ted Gansler, MD, MBA, MPH, Editor, reports that he has no financial relationships or interests to disclose.
Durado Brooks, MD, MPH, Associate Editor, is a Steering Committee member of the National Colorectal Cancer Roundtable, which is supported by the American Cancer Society and receives partial funding from the Centers for Disease Control and Prevention to support initiatives related to colorectal cancer screening. Dr. Brooks reports no other conflicts of interest.
Keith A. Delman, MD, FACS, Associate Editor, reports that he has no financial relationships or interests to disclose. Walter J. Curran, Jr., MD, Editorial Advisory Board, reports that he has no financial relationships or interests to disclose.
Gini Fleming, MD, Editorial Advisory Board, serves as co-Principal Investigator for Investigator Initiated Trials supported by Bristol-Myers Squibb, Clovis Oncology, and Corcept Therapeutics. Dr. Fleming reports no other conflicts of interest.
Susan Gapstur, PhD, MPH, Editorial Advisory Board, serves as member at large of the American Society of Preventive Oncology steering committee, is on the advisory committee of GRAIL, and serves on the T32 Training Program Advisory Committee for the post-doctoral fellowship program at the University of Illinois. Dr. Gapstur reports no other conflicts of interest.
Frederick L. Greene, MD, Editorial Advisory Board, reports that he has no financial relationships or interests to disclose.
Ahmedin Jemal, DVM, PhD, Editorial Advisory Board, is employed by the American Cancer Society and works in the intramural research department, which received a grant from Merck Inc for research outside the submitted work; however, his salary is solely funded through American Cancer Society funds. Dr. Jemal reports no other conflicts of interest.
Cathy Meade, PhD, RN, FAAN, Editorial Advisory Board, reports that she has no financial relationships or interests to disclose.
Kevin Oeffinger, MD, Editorial Advisory Board, reports that he has no financial relationships or interests to disclose.
William Oh, MD, Editorial Advisory Board, has served as a consultant for Amgen, AstraZeneca, Bayer, Churchill Pharmaceuticals, Dandreon, Janssen Pharmaceuticals, and Sanofi. Dr. Oh reports no other conflicts of interest.
Nancy D. Perrier, MD, FACS, Associate Editor, reports that she has no financial relationships or interests to disclose. William Phelps, PhD, Editorial Advisory Board, reports that he has no financial relationships or interests to disclose. Charles R. Thomas, Jr., MD, Editorial Advisory Board, reports that he has no financial relationships or interests to disclose.
Andrew Vickers, PhD, Editorial Advisory Board, is a co-inventor on a patent application for a statistical method to predict the result of prostate biopsy for Arctic Partners and is also a co-inventor of the 4kscore, a commercially available reflex test for predicting prostate biopsy, and may receive royalties from the sales of the test and owns stock options in OPKO, which offers the test. Dr. Vickers reports no other conflicts of interest.
|